Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung Cancer
Assessment of Quality of Life (QOL) in Patients Registered With Phase III Randomized Comparison Study of Vinorelbine, Gemcitabine, and Docetaxel Versus Paclitaxel and Carboplatin in Patients With Advanced Non-Small Cell Lung Cancer (JMTO LC00-03)
Sponsor: National Hospital Organization Kinki-chuo Chest Medical Center
A observational or N/A phase clinical study on Lung Cancer, this trial is ongoing. The trial is conducted by National Hospital Organization Kinki-chuo Chest Medical Center and has accumulated 7 data snapshots since 2004. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Unknown Status
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Unknown Status NA
First recorded
Apr 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Hospital Organization Kinki-chuo Chest Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aichi, Japan , Asahikawa, Japan , Chiba-ken, Japan , Ehime, Japan , Gumna, Japan , Gunma, Japan , Hokkaido, Japan , Hyōgo, Japan , Kanagawa, Japan , Kyoto, Japan and 7 more locations